» Articles » PMID: 33708539

Analysis of Primary and Secondary Squamous Cell Carcinoma of the Thyroid Gland: a Retrospective Study

Overview
Journal Gland Surg
Specialty Endocrinology
Date 2021 Mar 12
PMID 33708539
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Squamous cell carcinoma of the thyroid (SCCT) is a kind of rare malignant disease. This study aimed to analyse the clinical characteristics of patients with primary SCCT (PSCCT) and secondary SCCT (SSCCT).

Methods: The medical records of seventeen patients with PSCCT and six patients with SSCCT were reviewed. Clinical symptoms, ultrasound, and pathological characteristics were compared between the two groups.

Results: The mean age of diagnosis was approximately 56 years old in each group. The most common chief complaint of the patients was neck mass in both groups. The percentage of patients with cough (P=0.008) or weight loss (P=0.021) was higher in the SSCCT group than the PSCCT group. The mean size of the tumor in the PSCCT group was larger than that in the SSCCT group (3.382±2.011 1.950±0.794 cm, P=0.024). Papillary thyroid carcinoma (PTC) could be combined with or recur as PSCCT. Kaplan-Meier analysis indicated that the mean survival times after diagnosis were 17.053 months in the PSCCT patients and 13.500 months in the SSCCT patients. Multivariate survival analysis using a Cox regression model demonstrated that predictors of overall survival (OS) in PSCCT patients included age (P=0.020), enlarged cervical lymph node (P=0.017), radical operation (P=4.82×10), and PTC (P=0.03).

Conclusions: SCCT is aggressive, with neck mass being the most common chief complaint. There were several different characteristics between PSCCT and SSCCT. PTC could be combined with or recur as PSCCT. Age, enlarged cervical lymph node, radical operation, and PTC were the predictors of OS in PSCCT patients.

Citing Articles

Repeated misdiagnosis of squamous cell carcinoma of the thyroid: a case report.

Yu Z, Tingting D, Jianyong Z, Yunsong P Front Oncol. 2025; 15:1551514.

PMID: 40061900 PMC: 11885893. DOI: 10.3389/fonc.2025.1551514.


Risk factors of cervical lymph node metastasis and distant metastasis in patients with primary squamous cell carcinoma of the thyroid: a population-based study.

Lin X, Li J, Yin J, Li M Updates Surg. 2025; .

PMID: 40035921 DOI: 10.1007/s13304-025-02143-y.


Ultrasound combined with contrast‑enhanced ultrasound in the diagnosis of primary squamous cell carcinoma of the thyroid: A case report and literature review.

Chen C, Xu Q, Deng Y, Peng J, He X, Liu L Oncol Lett. 2025; 29(3):131.

PMID: 39822939 PMC: 11737294. DOI: 10.3892/ol.2025.14877.


A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.

Tian Y, He L, Zhang B, Deng L, Wang J Technol Cancer Res Treat. 2024; 23:15330338241254059.

PMID: 38725285 PMC: 11085001. DOI: 10.1177/15330338241254059.


To diagnose primary and secondary squamous cell carcinoma of the thyroid with ultrasound malignancy risk stratification.

Zhang X, Wei B, Nong L, Zhang H, Zhang J, Ye J Front Endocrinol (Lausanne). 2024; 14:1238775.

PMID: 38495474 PMC: 10940438. DOI: 10.3389/fendo.2023.1238775.


References
1.
Zhou X . Primary squamous cell carcinoma of the thyroid. Eur J Surg Oncol. 2002; 28(1):42-5. DOI: 10.1053/ejso.2001.1180. View

2.
Michelow P, Leiman G . Metastases to the thyroid gland: diagnosis by aspiration cytology. Diagn Cytopathol. 1995; 13(3):209-13. DOI: 10.1002/dc.2840130306. View

3.
Yang S, Li C, Shi X, Ma B, Xu W, Jiang H . Primary Squamous Cell Carcinoma in the Thyroid Gland: A Population-Based Analysis Using the SEER Database. World J Surg. 2019; 43(5):1249-1255. DOI: 10.1007/s00268-019-04906-2. View

4.
Cai L, Chen Y, Huang Z, Wu J . Primary squamous cell carcinoma of the thyroid on FDG PET/CT. Clin Nucl Med. 2014; 39(11):1014-6. DOI: 10.1097/RLU.0000000000000511. View

5.
Fassan M, Pennelli G, Pelizzo M, Rugge M . Primary squamous cell carcinoma of the thyroid: immunohistochemical profile and literature review. Tumori. 2007; 93(5):518-21. DOI: 10.1177/030089160709300522. View